Cargando…

Synthetic metabolic engineering-a novel, simple technology for designing a chimeric metabolic pathway

BACKGROUND: The integration of biotechnology into chemical manufacturing has been recognized as a key technology to build a sustainable society. However, the practical applications of biocatalytic chemical conversions are often restricted due to their complexities involving the unpredictability of p...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Xiaoting, Honda, Kohsuke, Sakai, Takaaki, Okano, Kenji, Omasa, Takeshi, Hirota, Ryuichi, Kuroda, Akio, Ohtake, Hisao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512521/
https://www.ncbi.nlm.nih.gov/pubmed/22950411
http://dx.doi.org/10.1186/1475-2859-11-120
_version_ 1782251745327448064
author Ye, Xiaoting
Honda, Kohsuke
Sakai, Takaaki
Okano, Kenji
Omasa, Takeshi
Hirota, Ryuichi
Kuroda, Akio
Ohtake, Hisao
author_facet Ye, Xiaoting
Honda, Kohsuke
Sakai, Takaaki
Okano, Kenji
Omasa, Takeshi
Hirota, Ryuichi
Kuroda, Akio
Ohtake, Hisao
author_sort Ye, Xiaoting
collection PubMed
description BACKGROUND: The integration of biotechnology into chemical manufacturing has been recognized as a key technology to build a sustainable society. However, the practical applications of biocatalytic chemical conversions are often restricted due to their complexities involving the unpredictability of product yield and the troublesome controls in fermentation processes. One of the possible strategies to overcome these limitations is to eliminate the use of living microorganisms and to use only enzymes involved in the metabolic pathway. Use of recombinant mesophiles producing thermophilic enzymes at high temperature results in denaturation of indigenous proteins and elimination of undesired side reactions; consequently, highly selective and stable biocatalytic modules can be readily prepared. By rationally combining those modules together, artificial synthetic pathways specialized for chemical manufacturing could be designed and constructed. RESULTS: A chimeric Embden-Meyerhof (EM) pathway with balanced consumption and regeneration of ATP and ADP was constructed by using nine recombinant E. coli strains overproducing either one of the seven glycolytic enzymes of Thermus thermophilus, the cofactor-independent phosphoglycerate mutase of Pyrococcus horikoshii, or the non-phosphorylating glyceraldehyde-3-phosphate dehydrogenase of Thermococcus kodakarensis. By coupling this pathway with the Thermus malate/lactate dehydrogenase, a stoichiometric amount of lactate was produced from glucose with an overall ATP turnover number of 31. CONCLUSIONS: In this study, a novel and simple technology for flexible design of a bespoke metabolic pathway was developed. The concept has been testified via a non-ATP-forming chimeric EM pathway. We designated this technology as “synthetic metabolic engineering”. Our technology is, in principle, applicable to all thermophilic enzymes as long as they can be functionally expressed in the host, and thus would be potentially applicable to the biocatalytic manufacture of any chemicals or materials on demand.
format Online
Article
Text
id pubmed-3512521
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35125212012-12-04 Synthetic metabolic engineering-a novel, simple technology for designing a chimeric metabolic pathway Ye, Xiaoting Honda, Kohsuke Sakai, Takaaki Okano, Kenji Omasa, Takeshi Hirota, Ryuichi Kuroda, Akio Ohtake, Hisao Microb Cell Fact Research BACKGROUND: The integration of biotechnology into chemical manufacturing has been recognized as a key technology to build a sustainable society. However, the practical applications of biocatalytic chemical conversions are often restricted due to their complexities involving the unpredictability of product yield and the troublesome controls in fermentation processes. One of the possible strategies to overcome these limitations is to eliminate the use of living microorganisms and to use only enzymes involved in the metabolic pathway. Use of recombinant mesophiles producing thermophilic enzymes at high temperature results in denaturation of indigenous proteins and elimination of undesired side reactions; consequently, highly selective and stable biocatalytic modules can be readily prepared. By rationally combining those modules together, artificial synthetic pathways specialized for chemical manufacturing could be designed and constructed. RESULTS: A chimeric Embden-Meyerhof (EM) pathway with balanced consumption and regeneration of ATP and ADP was constructed by using nine recombinant E. coli strains overproducing either one of the seven glycolytic enzymes of Thermus thermophilus, the cofactor-independent phosphoglycerate mutase of Pyrococcus horikoshii, or the non-phosphorylating glyceraldehyde-3-phosphate dehydrogenase of Thermococcus kodakarensis. By coupling this pathway with the Thermus malate/lactate dehydrogenase, a stoichiometric amount of lactate was produced from glucose with an overall ATP turnover number of 31. CONCLUSIONS: In this study, a novel and simple technology for flexible design of a bespoke metabolic pathway was developed. The concept has been testified via a non-ATP-forming chimeric EM pathway. We designated this technology as “synthetic metabolic engineering”. Our technology is, in principle, applicable to all thermophilic enzymes as long as they can be functionally expressed in the host, and thus would be potentially applicable to the biocatalytic manufacture of any chemicals or materials on demand. BioMed Central 2012-09-06 /pmc/articles/PMC3512521/ /pubmed/22950411 http://dx.doi.org/10.1186/1475-2859-11-120 Text en Copyright ©2012 Ye et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Ye, Xiaoting
Honda, Kohsuke
Sakai, Takaaki
Okano, Kenji
Omasa, Takeshi
Hirota, Ryuichi
Kuroda, Akio
Ohtake, Hisao
Synthetic metabolic engineering-a novel, simple technology for designing a chimeric metabolic pathway
title Synthetic metabolic engineering-a novel, simple technology for designing a chimeric metabolic pathway
title_full Synthetic metabolic engineering-a novel, simple technology for designing a chimeric metabolic pathway
title_fullStr Synthetic metabolic engineering-a novel, simple technology for designing a chimeric metabolic pathway
title_full_unstemmed Synthetic metabolic engineering-a novel, simple technology for designing a chimeric metabolic pathway
title_short Synthetic metabolic engineering-a novel, simple technology for designing a chimeric metabolic pathway
title_sort synthetic metabolic engineering-a novel, simple technology for designing a chimeric metabolic pathway
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512521/
https://www.ncbi.nlm.nih.gov/pubmed/22950411
http://dx.doi.org/10.1186/1475-2859-11-120
work_keys_str_mv AT yexiaoting syntheticmetabolicengineeringanovelsimpletechnologyfordesigningachimericmetabolicpathway
AT hondakohsuke syntheticmetabolicengineeringanovelsimpletechnologyfordesigningachimericmetabolicpathway
AT sakaitakaaki syntheticmetabolicengineeringanovelsimpletechnologyfordesigningachimericmetabolicpathway
AT okanokenji syntheticmetabolicengineeringanovelsimpletechnologyfordesigningachimericmetabolicpathway
AT omasatakeshi syntheticmetabolicengineeringanovelsimpletechnologyfordesigningachimericmetabolicpathway
AT hirotaryuichi syntheticmetabolicengineeringanovelsimpletechnologyfordesigningachimericmetabolicpathway
AT kurodaakio syntheticmetabolicengineeringanovelsimpletechnologyfordesigningachimericmetabolicpathway
AT ohtakehisao syntheticmetabolicengineeringanovelsimpletechnologyfordesigningachimericmetabolicpathway